Tenet Healthcare (NYSE:THC) Share Price Crosses Above 200-Day Moving Average - Here's Why

Key Points

• Tenet Healthcare (THC) crossed above its 200-day moving average (200‑day MA $205.31), trading as high as $206.48 and last at $200.68 on a roughly 3.1% intraday gain with about 1.7 million shares changing hands.
• Several analysts (Truist, Barclays, RBC, Mizuho, Cantor Fitzgerald) have raised price targets and maintain buy/outperform ratings, leaving a MarketBeat consensus target of $250.56 and an overall "Moderate Buy" rating.
• Tenet posted a quarterly earnings beat with $4.70 EPS vs. $4.08 expected and $5.53B revenue, and provided FY2026 guidance of 16.190–18.470 EPS, alongside solid margins and ROE metrics.

Tenet Healthcare Corporation (NYSE:THC - Get Free Report) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $205.31 and traded as high as $206.48. Tenet Healthcare shares last traded at $200.6750, with a volume of 1,699,761 shares changing hands.

Wall Street Analysts Forecast Growth

THC has been the topic of several research analyst reports. Truist Financial lifted their target price on shares of Tenet Healthcare from $240.00 to $270.00 and gave the company a "buy" rating in a research report on Tuesday, February 17th. Barclays lifted their target price on shares of Tenet Healthcare from $240.00 to $257.00 and gave the company an "overweight" rating in a research report on Friday, February 13th. Royal Bank Of Canada lifted their target price on shares of Tenet Healthcare from $253.00 to $277.00 and gave the company an "outperform" rating in a research report on Thursday, February 12th. Cantor Fitzgerald reiterated an "overweight" rating on shares of Tenet Healthcare in a research report on Wednesday, March 4th. Finally, Mizuho lifted their target price on shares of Tenet Healthcare from $235.00 to $265.00 and gave the company an "outperform" rating in a research report on Thursday, March 12th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $250.56.

Tenet Healthcare Stock Up 3.1%

The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. The stock has a market capitalization of $17.45 billion, a price-to-earnings ratio of 12.96, a price-to-earnings-growth ratio of 0.91 and a beta of 1.49. The business's 50-day moving average is $213.80 and its two-hundred day moving average is $205.31.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, beating the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. Tenet Healthcare's revenue was up 8.9% on a year-over-year basis. During the same period in the previous year, the business posted $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities analysts anticipate that Tenet Healthcare Corporation will post 12.24 EPS for the current year.

Insider Buying and Selling at Tenet Healthcare

In other news, EVP Paola M. Arbour sold 6,500 shares of the business's stock in a transaction that occurred on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total value of $1,549,795.00. Following the sale, the executive vice president directly owned 29,291 shares of the company's stock, valued at approximately $6,983,853.13. The trade was a 18.16% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider R. Scott Ramsey sold 8,017 shares of the business's stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $232.70, for a total transaction of $1,865,555.90. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 46,517 shares of company stock worth $10,943,111 in the last ninety days. 0.81% of the stock is owned by insiders.

Institutional Investors Weigh In On Tenet Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in THC. Triumph Capital Management purchased a new stake in Tenet Healthcare during the 3rd quarter worth approximately $25,000. Activest Wealth Management acquired a new position in Tenet Healthcare during the 4th quarter worth approximately $26,000. Elyxium Wealth LLC acquired a new position in Tenet Healthcare during the 4th quarter worth approximately $29,000. William B. Walkup & Associates Inc. acquired a new position in Tenet Healthcare during the 3rd quarter worth approximately $32,000. Finally, Westside Investment Management Inc. grew its holdings in Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company's stock worth $39,000 after acquiring an additional 96 shares in the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.